Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.
A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer's—tau protein and beta-amyloid ...